Recently, we reported a novel model of secondary progressive multiple sclerosis (SPMS) induced by immunization with myelin oligodendrocyte glycoprotein peptide 35–55 (MOG35–55) in oligodendroglia-specific Cx47-inducible conditional knockout (Cx47 icKO) mice [14]. Here, GJC2 is linked to secondary progressive multiple sclerosis.